Klinik Arlesheim
Arlesheim, Schweiz
Behandlung & Zugang
- Angebotene Behandlungenesketamine (Spravato)
- ZugangswegDurch ein nationales Programm übernommen
- Kosten & Übernahme (Registerstatus)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ErstattungBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 So funktioniert die Erstattung in Europa →
- Telefon+41 61 705 71 11
- Websitehttps://www.klinik-arlesheim.ch
Über diesen Anbieter
Klinik Arlesheim is an acute hospital for anthroposophic medicine in Arlesheim (canton Basel-Landschaft) whose psychiatry and psychosomatics unit treats adults from age 18 in outpatient consultations and on two open inpatient wards (general psychiatry and psychosomatics). Treatment is based on conventional medicine, extended by integrative anthroposophic psychiatry, milieu-therapeutic ward concepts, integrative nursing and artistic therapies. Its public pages do not describe a dedicated esketamine programme, so ask the psychiatry secretariat how Spravato treatment is arranged.
Leistungen & Programme
- Outpatient psychiatric consultations
- Inpatient psychiatry ward (open, general psychiatric)
- Inpatient psychosomatics ward
- Biography work and group therapy offers
- Artistic therapies (eurythmy therapy, painting, music, therapeutic speech)
- Physiotherapy
- Anthroposophic nursing
Häufige Fragen
How do I get admitted for depression treatment at Klinik Arlesheim?
For inpatient treatment the clinic requires referral by a family doctor or psychiatrist, followed by a clarification consultation that is part of the treatment; outpatient appointments are booked via the psychiatry/psychosomatics secretariat (+41 61 705 72 81).
What are the Swiss insurance conditions for Spravato?
Under the BAG Limitatio, basic insurance covers esketamine nasal spray for adults 18-74 with treatment-resistant depression (at least two antidepressants with different mechanisms plus one augmentation attempt failed, confirmed severity) only after the insurer's cost approval (Kostengutsprache) is granted before the first dose, for a maximum of 10 months.
Verifizierung
- Lizenz / RegisterBAG SL Limitatio
- Quellehttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Zuletzt verifiziert